Online citations, reference lists, and bibliographies.
← Back to Search

Laminin α1 Chain Mediated Reduction Of Laminin α2 Chain Deficient Muscular Dystrophy Involves Integrin α7β1 And Dystroglycan

K. Gawlik, U. Mayer, Kristina Blomberg, A. Sonnenberg, P. Ekblom, M. Durbeej
Published 2006 · Biology

Cite This
Download PDF
Analyze on Scholarcy
Transgenically introduced laminin (LN) α1 chain prevents muscular dystrophy in LNα2 chain deficient mice. We now report increased integrin α7Bβ1D synthesis in dystrophic LNα2 chain deficient muscle. Yet, immunofluorescence demonstrated a reduced expression of integrin α7B subunit at the sarcolemma. Transgenic expression of LNα1 chain reconstituted integrin α7B at the sarcolemma. Expression of α‐ and β‐dystroglycan is enhanced in LNα2 chain deficient muscle and normalized by transgenic expression of LNα1 chain. We suggest that LNα1 chain in part ameliorates the development of LNα2 chain deficient muscular dystrophy by retaining the binding sites for integrin α7Bβ1D and α‐dystroglycan, respectively.
This paper references
Laminin a1 chain corrects male infertility caused by absence of laminin
M. Häger (2005)
Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse
P. K. Grewal (2001)
Laminin a2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy
Y. Miyagoe (1997)
Genetic compensation for sarcoglycan loss by integrin α7β1 in muscle
M. Allikian (2004)
Dystroglycan: important player in skeletal muscle and beyond
R. Cohn (2005)
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy
J. Moll (2001)
Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
P. Vachon (1997)
Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models.
Wenhua Kuang (1998)
Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies
D. Michele (2002)
Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
O. Ibraghimov-Beskrovnaya (1992)
Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice
K. Gawlik (2004)
Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy
A. Helbling-Leclerc (1995)
Congenital muscular dystrophies.
E. Mercuri (2002)
Absence of integrin α7 causes a novel form of muscular dystrophy
U. Mayer (1997)
Mutations in CDMP1 cause autosomal dominant brachydactyly type C
A. Polinkovsky (1997)
Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses
P. D. Côté (1999)
Mutations in the laminin a2 chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy
A. Helbling-Leclerc (1995)
Laminin a 1 chain corrects male infertility caused by absence of laminin a 2 chain
M. Häger (2005)
A simplified laminin nomenclature.
M. Aumailley (2005)
Integrins: Redundant or Important Players in Skeletal Muscle?*
U. Mayer (2003)
Mutations in the integrin α7 gene cause congenital myopathy
Y. Hayashi (1998)
Overexpression of mini‐agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin‐α2‐deficient mice
C. Florian Bentzinger (2005)
Mutant glycosyltransferase and altered glycosylation of a- K.I
P. K. Grewal (2001)
Altered expression of the integrin a7b1 integrin in human and murine muscular dystrophies
B. S. Hodges (1997)
Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice
Vianney Jayasinha (2003)
Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.
M. Girgenrath (2004)
Integrins (a7b1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy
P. H. Vachon (1997)
Enhanced Expression of the α7β1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice
D. Burkin (2001)
Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies.
B. L. Hodges (1997)
Laminin {alpha}1 chain corrects male infertility caused by absence of laminin {alpha}2 chain.
M. Häger (2005)
Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration
R. Cohn (2002)
Secondary reduction of α7B integrin in laminin α2 deficient congenital muscular dystrophy supports an additional transmembrane link in skeletal muscle
R. Cohn (1999)
Spatial and Temporal Expression of the b1D Integrin During Mouse Development
A. V. D. Flier (1997)
Spatial and temporal expression of the β1D integrin during mouse development
A. van der Flier (1997)
Laminin α2 chain‐null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)‐deficient congenital muscular dystrophy
Y. Miyagoe (1997)
Alternative Splice Variants of α7β1Integrin Selectively Recognize Different Laminin Isoforms*
H. von der Mark (2002)
Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α‐dystroglycan and several extracellular matrix proteins
J. Talts (1999)
Membrane organization of the dystrophin-glycoprotein complex
J. Ervasti (1991)
Defective integrin switch and matrix composition at alpha 7-deficient myotendinous junctions precede the onset of muscular dystrophy in mice.
R. Nawrotzki (2003)

This paper is referenced by
Cib2 Binds Integrin α7Bβ1D and Is Reduced in Laminin α2 Chain-deficient Muscular Dystrophy*
M. Häger (2008)
Intrinsic laryngeal muscles are spared from degeneration in the dy3k/dy3k mouse model of congenital muscular dystrophy type 1A
M. Häger (2009)
Laminin isoforms in development and disease
Susanne Schéele (2007)
Correlation of dystrophin–glycoprotein complex and focal adhesion complex with myosin heavy chain isoforms in rat skeletal muscle
S. Masuda (2009)
Epistatic dissection of laminin-receptor interactions in dystrophic zebrafish muscle.
T. Sztal (2012)
An Immunological Analysis of Dystroglycan Subunits: Lessons Learned from a Small Cohort of Non-Congenital Dystrophic Patients
E. Pavoni (2011)
Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice
K. Gawlik (2015)
Distinct Roles for Laminin Globular Domains in Laminin α1 Chain Mediated Rescue of Murine Laminin α2 Chain Deficiency
K. Gawlik (2010)
Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy
A. Nunes (2017)
Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy
Quynh Nguyen (2019)
Unraveling the genotypic and phenotypic complexities of genetic hearing loss
K. Booth (2018)
Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A.
A. Kumar (2011)
The myotomal basement membrane
A. Borycki (2013)
Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dyW mouse model of merosin-deficient congenital muscular dystrophy type 1A
Jinger A. Doe (2011)
Laminin differentially regulates the stemness of type I and type II pericytes
Jyoti Gautam (2017)
Laminin-211 in skeletal muscle function
Johan Holmberg (2013)
Laminin α1 reduces muscular dystrophy in dy2J mice.
K. Gawlik (2018)
Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
K. Gawlik (2014)
A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
K. Gawlik (2020)
Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
Pamela Barraza-Flores (2020)
Laminin alpha1 chain improves laminin alpha2 chain deficient peripheral neuropathy.
K. Gawlik (2006)
Quantitative Proteomic Analysis Reveals Metabolic Alterations, Calcium Dysregulation, and Increased Expression of Extracellular Matrix Proteins in Laminin α2 Chain–deficient Muscle*
Bruno Menezes de Oliveira (2014)
Type IV Collagens and Basement Membrane Diseases: Cell Biology and Pathogenic Mechanisms.
M. Mao (2015)
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy?
F. Sciandra (2007)
Human Myoblast Engraftment Is Improved in Laminin-Enriched Microenvironment
S. D. Silva-Barbosa (2008)
Allelic heterogeneity contributes to variability in ocular dysgenesis, myopathy and brain malformations caused by Col4a1 and Col4a2 mutations
D. Kuo (2014)
Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.
M. Durbeej (2015)
CIB2, defective in isolated deafness, is key for auditory hair cell mechanotransduction and survival
Vincent Michel (2017)
Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy.
P. V. Van Ry (2014)
Laminin 1 chain improves laminin 2 chain deficient peripheral neuropathy
K. Gawlik (2006)
Laminin isoforms in atherosclerotic arteries from mice and man.
U. Rauch (2011)
Collagen XV, a novel factor in zebrafish notochord differentiation and muscle development.
Aurélie Pagnon-Minot (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar